CIZ | DSTX | CIZ / DSTX | |
Gain YTD | 9.282 | 0.292 | 3,184% |
Net Assets | 24M | 32.8M | 73% |
Total Expense Ratio | N/A | N/A | - |
Turnover | 320.00 | 102.00 | 314% |
Yield | 3.23 | 1.78 | 181% |
Fund Existence | 10 years | 4 years | - |
CIZ | DSTX | |
---|---|---|
RSI ODDS (%) | N/A | N/A |
Stochastic ODDS (%) | 26 days ago75% | 6 days ago74% |
Momentum ODDS (%) | N/A | 6 days ago86% |
MACD ODDS (%) | N/A | N/A |
TrendWeek ODDS (%) | 26 days ago69% | 6 days ago77% |
TrendMonth ODDS (%) | 26 days ago68% | 6 days ago73% |
Advances ODDS (%) | N/A | 13 days ago73% |
Declines ODDS (%) | N/A | 6 days ago77% |
BollingerBands ODDS (%) | 26 days ago82% | 6 days ago83% |
Aroon ODDS (%) | N/A | 6 days ago65% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
EMRGX | 6.82 | -0.03 | -0.44% |
Emerging Markets Growth Fund M | |||
ICPUX | 5.99 | -0.03 | -0.50% |
Integrity Mid-North American Resources C | |||
FZILX | 11.73 | -0.06 | -0.51% |
Fidelity ZERO International Index | |||
MSCLX | 19.31 | -0.26 | -1.33% |
MassMutual Small Cap Opps Adm | |||
PHPIX | 26.83 | -1.12 | -4.01% |
ProFunds Pharmaceuticals UltraSector Inv |
A.I.dvisor indicates that over the last year, CIZ has been loosely correlated with BAM. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if CIZ jumps, then BAM could also see price increases.
A.I.dvisor indicates that over the last year, DSTX has been loosely correlated with NXT. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if DSTX jumps, then NXT could also see price increases.
Ticker / NAME | Correlation To DSTX | 1D Price Change % | ||
---|---|---|---|---|
DSTX | 100% | +0.04% | ||
NXT - DSTX | 33% Loosely correlated | -7.44% | ||
RHHBY - DSTX | 23% Poorly correlated | -0.83% | ||
HEI - DSTX | 17% Poorly correlated | -2.39% | ||
PBR - DSTX | 13% Poorly correlated | +0.86% | ||
ALL - DSTX | 11% Poorly correlated | +0.56% | ||
More |